2
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Sjogren's Syndrome
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Interventions
Rituximab
1402
Cyclophosphamide
1308
Vincristine
670
Doxorubicin
589
Etoposide
527
Prednisone
512
Cytarabine
487
fludarabine
470
Methotrexate
446
Dexamethasone
414
fludarabine phosphate
400
Lenalidomide
356
Filgrastim
343
Bendamustine Hydrochloride
283
Radiotherapy
267
venetoclax
261
ibrutinib
258
obinutuzumab
236
Peripheral Blood Stem Cell Transplantation
234
Melphalan
230
Granulocyte Colony-Stimulating Factor
215
Bortezomib
204
Gemcitabine
202
Busulfan
188
Whole-Body Irradiation
187
Mycophenolic Acid
175
Tacrolimus
165
Specimen Handling
164
Magnetic Resonance Spectroscopy
157
Calcium Dobesilate
151
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
belimumab
×
Lymphoid
×
Clear all
NCT06410833
2024-05-16
BRRPJS
Peking Union Medical College Hospital
Phase 4
Recruiting
15 enrolled